Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis
- PMID: 8000297
Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis
Abstract
Pulmonary diseases attributable to asbestos exposure constitute a significant public health burden, yet few studies have investigated potential genetic determinants of susceptibility to asbestos-related diseases. The glutathione-S-transferases are a family of conjugating enzymes that both catalyze the detoxification of a variety of potentially cytotoxic electrophilic agents and act in the generation of sulfadipeptide leukotriene inflammatory mediators. The gene encoding glutathione-S-transferase class mu (GSTM-1) is polymorphic; approximately 50% of Caucasian individuals have a homozygous deletion of this gene and do not produce functional enzyme. Glutathione-S-transferase mu (GST-mu) deficiency has been previously reported to be associated with smoking-induced lung cancer. We conducted a cross-sectional study to examine the prevalence of the homozygous deletion for the GSTM-1 gene in members of the carpentry trade occupationally exposed to asbestos. Members of the United Brotherhood of Carpenters and Joiners of America attending their 1991 National Union conference were invited to participate. Each participant was offered a chest X-ray and was asked to complete a comprehensive questionnaire and have their blood drawn. All radiographs were assessed for the presence of pneumoconiosis in a blinded fashion by a National Institute for Occupational Safety and Health-certified International Labor Office "B" reader. Individual GSTM-1 status was determined using polymerase chain reaction methods. Six hundred fifty-eight workers were studied. Of these, 80 (12.2%) had X-ray abnormalities associated with asbestos exposure. Individuals genetically deficient in GST-mu were significantly more likely to have radiographic evidence of nonmalignant asbestos-related disease than those who were not deficient (chi 2 = 5.0; P < 0.03).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
The glutathione S-transferase theta and mu deletion polymorphisms in asbestosis.Am J Ind Med. 1997 Mar;31(3):274-9. doi: 10.1002/(sici)1097-0274(199703)31:33.0.co;2-y. Am J Ind Med. 1997. PMID: 9055949
-
Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.Neoplasma. 1998;45(5):312-7. Neoplasma. 1998. PMID: 9921921
-
Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases.Cancer Epidemiol Biomarkers Prev. 1997 Jul;6(7):511-5. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9232338
-
Significance of genetic polymorphisms in glutathione S-transferase multigene family and lung cancer risk.Int J Occup Med Environ Health. 2001;14(2):99-113. Int J Occup Med Environ Health. 2001. PMID: 11548073 Review.
-
[Glutathione S-transferase mu 1 (GSTM1): susceptibility gene of breast cancer].Bull Cancer. 1997 Jan;84(1):35-40. Bull Cancer. 1997. PMID: 9180857 Review. French.
Cited by
-
Health effects of asbestos and nonasbestos fibers.Environ Health Perspect. 2000 Aug;108 Suppl 4(Suppl 4):665-74. doi: 10.1289/ehp.00108s4665. Environ Health Perspect. 2000. PMID: 10931785 Free PMC article. Review.
-
Models of interaction between metabolic genes and environmental exposure in cancer susceptibility.Environ Health Perspect. 1998 Feb;106(2):67-70. doi: 10.1289/ehp.9810667. Environ Health Perspect. 1998. PMID: 9435152 Free PMC article.
-
A retired shipyard worker with rapidly progressive pulmonary interstitial fibrosis.Environ Health Perspect. 1999 Apr;107(4):321-7. doi: 10.1289/ehp.99107321. Environ Health Perspect. 1999. PMID: 10090713 Free PMC article.
-
Manganese and extracellular superoxide dismutase polymorphisms and risk for asbestosis.J Biomed Biotechnol. 2009;2009:493083. doi: 10.1155/2009/493083. Epub 2009 Jul 14. J Biomed Biotechnol. 2009. PMID: 19636420 Free PMC article.
-
Effect of interaction of glutathione S-transferases (T1 and M1) on the hematologic and cytogenetic responses in chronic myeloid leukemia patients treated with imatinib.Med Oncol. 2014 Jul;31(7):47. doi: 10.1007/s12032-014-0047-z. Epub 2014 Jun 10. Med Oncol. 2014. PMID: 24913811 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous